(Q34080346)

English

Activation and control mechanisms of Hageman factor-dependent pathways of coagulation, fibrinolysis, and kinin generation and their contribution to the inflammatory response

scientific article published on December 1, 1975

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

Activation and control mechanisms of Hageman factor-dependent pathways of coagulation, fibrinolysis, and kinin generation and their contribution to the inflammatory response (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

blood coagulation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1107395

24 September 2023

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1107395

24 September 2023

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

author name string

A. P. Kaplan

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1107395

24 September 2023

K. F. Austen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1107395

24 September 2023

language of work or name

0 references

publication date

1 December 1975

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

full work available at URL

https://api.elsevier.com/content/article/PII:0091674975900676?httpAccept=text/xml

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

https://api.elsevier.com/content/article/PII:0091674975900676?httpAccept=text/plain

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

The Journal of Allergy and Clinical Immunology

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

56

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

491-506

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent

1

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator

3

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Role of Hageman Factor in the Activation of Vasodilator Activity in Human Plasma

4

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein

5

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator

6

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein

7

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation

8

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin

9

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Aggregation of platelets by collagen

13

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins).

14

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

THE INFLAMMATORY PROCESS IN ACUTE GOUTY ARTHRITIS. I. ACTIVATION OF HAGEMAN FACTOR BY SODIUM URATE CRYSTALS

15

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Activation of Hageman Factor by L-Homocystine

16

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

The Relation of ‘Fletcher Factor’ to Factors XI and XII

18

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Prekallikrein deficiency in man

19

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

The use of isoelectric focusing to study components of the human plasma kinin-forming system

21

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor).

22

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor).

27

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Susceptibility of the guinea pig to pharmacological factors from its own serum

29

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Substrates of Hageman factor. I. Isolation and characterization of human factor XI (PTA) and inhibition of the activated enzyme by alpha 1-antitrypsin

34

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein

37

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Isolation of Two Permeability Globulins from Human Serum

39

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Conversion of bovine prekallikrein to kallikrein. Evidence of limited proteolysis of prekallikrein by bovine hageman factor (factor XII)

41

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Plasma prekallikrein: isolation, characterization, and mechanism of activation

42

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Factor XII-induced fibrinolysis: studies on the separation of prekallikrein, plasminogen proactivator, and factor XI in human plasma.

43

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

The mechanism of clot retraction

46

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Factor V: an activator of factor Xa in the absence of prothrombin

49

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time.

50

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Von Willebrand factor: dissociation from antihemophilic factor procoagulant activity

53

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Factor VIII coagulant activity and factor VIII-like antigen: independent molecular entities

54

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Antigen-biological-activity ratio for factor VIII.

55

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Further evidence for an active center in streptokinase-plasminogen complex; interaction with pancreatic trypsin inhibitor

57

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Direct evidence for the generation of an active site in the plasminogen moiety of the streptokinase-human plasminogen activator complex

58

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Purification and characterization of streptokinase with studies of streptokinase activation of plasminogen

63

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Activation of human plasminogen by an insoluble derivative of urokinase. Structural changes of plasminogen in the course of activation to plasmin and demonstration of a possible intermediate compound

64

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Primary Structure of Peptides Released during Activation of Human Plasminogen by Urokinase

65

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

An immunochemical study of human plasminogen and plasmin

66

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Preparation of human kininogen. 3. Enzymatic digestion and modification.

70

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

The purification of a kininogen from human plasma

71

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Some data on two purified kininogens from human plasma

72

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Physicochemical Properties of Bovine Kininogen-II

73

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Separation of a New Substrate, Kininogen-I, for Plasma Kallikrein in Bovine Plasma*

74

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Structural features of plasma kinins and kininogens

75

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Evidence for the location of methionyl-lysyl-bradykinin moieties at the carboxyl terminus and inside of bovine kininogen-I

77

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Studies on the Chemical Nature of Bovine Bradykininogen: Determinations of Amino Acid, Carbohydrate, Amino and Carboxyl Terminal Residues*

78

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

The location and nature of the linkage of kinin moiety in bovine kininogen-II

79

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation

81

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Anticoagulant Action of Heparin

82

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Plasma inhibitors of the components of the fibrinolytic pathway in man

83

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Active Site Chemotactic Factors and the Regulation of the Human Neutrophil Chemotactic Response

84

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein

86

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Binding of thrombin to antithrombin III

90

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Factor-Xa inactivation by antithrombin. 3. Evidence for biological stabilization of factor Xa by factor V-phospholipid complex

93

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

An enzyme in human blood plasma that inactivates bradykinin and kallidins

95

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase.

96

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Second Kininase in Human Blood Plasma

97

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Peptide-bond hydrolysis equilibria in the antitrypsin site of lima bean protease inhibitor

99

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Degradation of human fibrinogen by plasms alpha2-macroglobulin-enzyme complexes

100

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

The complement system in necrotizing angiitis of the skin. Analysis of complement component activities in serum of patients with concomitant collagen-vascular diseases

101

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Rheumatoid factor and kinin generation

106

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Chemical studies of Clq; a modulator of immunoglobulin biology.

109

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

The Interaction of Hageman Factor and Immune Complexes

110

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Nature of peptides released by thrombin

112

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors

115

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

The conversion of C'IS to C'1 esterase by plasmin and trypsin

116

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

A plasmin-split fragment of C'3 as a new chemotactic factor

117

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

C3 proactivator convertase and its mode of action

118

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Modulation of function of the activated first component of complement by a fragment derived from serum. I. Effect on early components of complement

119

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets

120

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

A plasminogen proactivator-activator system in human blood effective in absence of Hageman Factor

121

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Fitzgerald Trait: Deficiency of a Hitherto Unrecognized Agent, Fitzgerald Factor, Participating in Surface-Mediated Reactions of Clotting, Fibrinolysis, Generation of Kinins, and the Property of Diluted Plasma Enhancing Vascular Permeability (PF/Dil

125

1 reference

10.1016/0091-6749(75)90067-6

https://api.crossref.org/works/10.1016/0091-6749(75)90067-6

24 September 2023

Identifiers

10.1016/0091-6749(75)90067-6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34080346&oldid=1980944144"